Tymlos

Tymlos (abaloparatide) is a prescription medication used to treat Osteoporosis. A once-daily injectable for postmenopausal women with osteoporosis at high risk of fracture, used to build new bone.

A PTHrP analog that stimulates bone-forming cells to increase bone density and strength.

Commonly reported side effects of Tymlos include Dizziness, Nausea, Headache, Heart palpitations, and Possible bone cancer risk seen in animal studies (boxed warning). This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Tymlos carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Tymlos is abaloparatide, which belongs to a class of medicines known as PTHrP Analog (Bone-Building Agent).

Tymlos is manufactured by Radius Health. It was first approved in 2017.

You may be able to lower the cost of Tymlos by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.